Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q5U3Y5

Entry ID Method Resolution Chain Position Source
AF-Q5U3Y5-F1 Predicted AlphaFoldDB

No variants for Q5U3Y5

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q5U3Y5

No associated diseases with Q5U3Y5

No regional properties for Q5U3Y5

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q5U3Y5

Functions

Description
EC Number
Subcellular Localization
  • Membrane ; Multi-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.

No GO annotations of molecular function

Name Definition
No GO annotations for molecular function

2 GO annotations of biological process

Name Definition
protein transport The directed movement of proteins into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
vesicle-mediated transport A cellular transport process in which transported substances are moved in membrane-bounded vesicles; transported substances are enclosed in the vesicle lumen or located in the vesicle membrane. The process begins with a step that directs a substance to the forming vesicle, and includes vesicle budding and coating. Vesicles are then targeted to, and fuse with, an acceptor membrane.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q5SSN7 Sft2d1 Vesicle transport protein SFT2A Mus musculus (Mouse) PR
10 20 30 40 50 60
MEKLRRVLSG QDDEEQGLTA QVLDASSLSF NTRLKWFVIC FVAGIFFSIL GTGLLWLPNG
70 80 90 100 110 120
VKLFAVFYTL GNLAALASTC FLMGPVKQLK KMFETTRLLA TIIMLLCLVF TLCAALWWRK
130 140 150
KGLALLFCIL QFLSMTWYSL SYIPYARDAV LKCCSSILS